Camlin Fine Sciences Ltd — Regulatory Filings 2021

Jul 7, 2021

==> picture [100 x 31] intentionally omitted <==

7[th] July, 2021

To,	To,
BSE Limited,	The Manager,
25, P. J. Towers,	Listing Department,
Dalal Street,	National Stock Exchange of India Ltd.,
Mumbai – 400 001	Exchange Plaza, Bandra Kurla Complex,
**Ref:**Company Scrip Code: 532834	Bandra (East), Mumbai‐ 400051
	**Ref:Symbol:**CAMLINFINE

Sub: Intimation of revision in Credit Rating

Dear Sir/Madam,

Pursuant to Regulation 30(6) read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that Credit Rating Agency, namely, India Ratings & Research Pvt. Ltd. (Fitch Group), vide its letter dated July 6, 2021, has upgraded the rating/outlook of the Company as follows:

Facility	Amount	Revised Rating	Rating	Remarks
	(in million)		Action
Term Loan	INR 395	IND A‐/Stable	Upgraded	Revised from IND
				BBB+/Stable
Fund‐based limits	INR 2,305	IND A‐/Stable/IND	Upgraded	Revised from IND
		A2+		BBB+/Stable/IND A2
Non‐Fund‐based limits	INR 1,618	IND A2+	Upgraded	Revised from IND A2

We request you to kindly take the above information on record.

Thanking You,

For Camlin Fine Sciences Limited

==> picture [55 x 52] intentionally omitted <==

==> picture [83 x 35] intentionally omitted <==

Mr. Mandar Godbole GM Legal, Company Secretary & Compliance Officer

==> picture [426 x 57] intentionally omitted <==